What are the possible side effects of prostate radiation therapy?

radiotherapy tolerance tests

SHORT VERSION

There are two types of side effects of prostate radiation therapy:

  • early/acute side effects, mainly urinary (difficulty or urgency to urinate), digestive (constipation, diarrhea, rectal pain) or sexual (erectile dysfunction and libido). These side effects can be managed with drugs prescribed by the radiation oncologist;
  • late side effects, mainly urinary (difficulty to urinate, traces of blood in urine), digestive (blood in stool) or sexual (erectile dysfunction). They appear between 3 months and 3 years after the treatment end and are irreversible. These complications are rare, less than 10% of patients will develop them. A specific management is put in place to limit their impact on the patient’s quality of life.

Like for all side effects of radiation therapy, the side effects of prostate radiation therapy can be classified in acute (occurring during and up to 3-6 months after treatment end) and late (more than 6 months after radiation therapy) side effects. It should be noted that their intensity and the risk of occurrence vary greatly among patients. These toxicities may concern the urinary, digestive systems, or the sexual function.

Acute side effects may concern the bladder (increase in the frequency of urination particularly at night, difficulty in urinating, burning urination, or urinary urgency). Digestive toxicities include diarrhea (or sometimes constipation), false feeling to pass stool, and pain in the rectal area. Sexually, erectile dysfunction and loss of libido may occur, especially if hormone therapy is concomitantly prescribed. These acute side effects are very well managed with symptomatic treatments (e.g. anti-diarrhea drugs, drugs to help urinating) that are prescribed, if necessary, by the radiation oncologist.

Late side effects are much less frequent, as less than 10% of patients will develop such complications. At the urinary level, they include difficulty in urinating (drugs to facilitate urination are prescribed), increased frequency of urination, or traces of blood in urine (due to radiation cystitis, which is similar to fibrosis of a part of the bladder). Digestive late toxicities are rare (presence of blood in stool due to radiation proctitis). These symptoms require specialized care because sometimes they can be quite disabling. Some patients experience erectile dysfunction that can be treated by a specialist.

Radiotherapy hair loss

5/5 - (1 vote)

FIRST TESTS TO PREDICT A PATIENT’S RADIOSENSITIVITY

NovaGray develops and commercializes the first radiotherapy tolerance tests for patients treated for breast or prostate cancer.

Performed before the start of radiotherapy with a simple blood draw, the tests assess the patients’ individual radiosensitivity and determine their risk of developing late complications after radiotherapy.

WHY DO A RADIOSENSITIVITY TEST?

Knowing a patient’s individual radiosensitivity is important information that can help:

  • Reassure the patient in preparation for radiotherapy
  • Guide physicians in choosing the most appropriate treatment plan
  • Adapt patient follow-up after radiotherapy

Team NovaGray

NovaGray develops radiotherapy tolerance tests for breast and prostate cancer patients. NovaGray's mission is to help personalize cancer treatment by assessing each patient's individual sensitivity before starting radiotherapy. NovaGray technology has been validated by multi-center prospective clinical trials. NovaGray tests are recommended by the French Society of Radiation Oncology (SFRO).